Harmonize care to optimize outcome in children and adolescents with diabetes mellitus: Treatment recommendations in Europe

Pediatric Diabetes

Volumn 13, Issue SUPPL. 16, 2012, Pages 15-19

  de Beaufort, Carine ^a   Vazeou, Andreani ^b   Sumnik, Zdenek ^c   Cinek, Ondrej ^c   Hanas, Ragnar ^d   Danne, Thomas ^e   Aschemeier, Bärbel ^e   Forsander, Gun ^f  

^a DECCP   (Luxembourg)

^b P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d UDDEVALLA HOSPITAL   (Sweden)

^e Diabetes Centre for Children and Adolescents   (Germany)

^f QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Children diabetes; ISPAD Clinical Practice Consensus Guidelines; SWEET

Indexed keywords

ARTICLE; AUSTRIA; BELGIUM; BULGARIA; CLINICAL PRACTICE; CYPRUS; CZECH REPUBLIC; DENMARK; DIABETES MELLITUS; ESTONIA; FINLAND; FRANCE; GERMANY; GREECE; HUMAN; HUNGARY; IRELAND; ITALY; LATVIA; LITHUANIA; LUXEMBOURG; MALTA; NETHERLANDS; NORWAY; PATIENT CARE; POLAND; PORTUGAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; ROMANIA; SLOVAKIA; SLOVENIA; SPAIN; SWEDEN; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE OF ONSET; CALIBRATION; CHILD; DIABETES MELLITUS; ENDOCRINOLOGY; EUROPE; GUIDELINE ADHERENCE; HEALTH PLANNING GUIDELINES; HUMANS; INTERNATIONAL COOPERATION; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; REFERENCE STANDARDS; SOCIETIES, MEDICAL; STANDARD OF CARE;

EID: 84865601385     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2012.00908.x     Document Type: Article

References (15)

1. Health & consumer protection directorate-general. Report on the work of the high Level Group on health services and medical care in 2008. HLG/2008/5 FINAL. Health & consumer protection directorate-general.
2. RDTF expert group. Final Report on the ECR. RDTF expert group
3. Di Iorio CT, Carinci F, Azzopardi J et al. Privacy impact assessment in the design of transnational public health information systems: the BIRO project. J Med Ethics 2009: 35: 753-761.
4. ISPAD. Clinical practice consensus guidelines. Pediatr Diabetes 2009: Suppl. 12: 1-210.
5. La Loggia A. Organization of Paediatric Diabetes Units in Italy. Acta Biomed 2005: 76 (Suppl. 3): 70-74.
6. Edge JA, Swift PG, Anderson W, Turner B; Youth and Family Advisory Committee of Diabetes UK. Diabetes services in the UK: fourth national survey; are we meeting NSF standards and NICE guidelines? Arch Dis Child 2005: 90: 1005-1009.
7. Gosden C, Edge JA, Holt RI et al. The fifth UK paediatric diabetes services survey: meeting guidelines and recommendations? Arch Dis Child 2010: 95: 837-840.
8. Draft Report: Recommendations for Diabetes Care and Treatment in Paediatric Centres of Reference in the EU 2009. SWEET Project (www.sweetproject.eu)
9. Maahs DM, Wadwa RP, Bishop F, Daniels SR, Rewers M, Klingensmith GJ. Dyslipidemia in youth with diabetes: to treat or not to treat? J Pediatr 2008: 153: 458-465.
10. Lind M, Oden A, Fahlen M, Eliasson B. The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables. PLoS One 2009: 4: e4412.
11. DCCT Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr 1994: 125: 177-188.
12. Swift PGF, Skinner TC, de Beaufort CE et al. Target setting in intensive insulin management is associated with better metabolic control: the Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005. Pediatr Diabetes 2010: 11: 271-278.
13. Cameron FJ, Skinner TC, de Beaufort CE et al; on behalf of the Hvidoere Study Group on Childhood Diabetes. Are family factors universally related to metabolic outcomes in adolescents with type 1 diabetes? Diabet Med 2008: 25: 463-468.
14. DAWN Diabetes Attitude, Wishes and Needs. (available from http://www.dawnstudy.com/).
15. Regulation (EC) No 1901/2006 of the European parliament and of the council 12 December 2006, on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance)